Daniel Stadlbauer to Humans
This is a "connection" page, showing publications Daniel Stadlbauer has written about Humans.
Connection Strength
0.047
-
Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City. Nature. 2021 02; 590(7844):146-150.
Score: 0.007
-
Anti-SARS-CoV-2 spike antibodies are stable in convalescent plasma when stored at 4° Celsius for at least 6 weeks. Transfusion. 2020 10; 60(10):2457-2459.
Score: 0.007
-
SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup. Curr Protoc Microbiol. 2020 06; 57(1):e100.
Score: 0.007
-
Universal influenza virus vaccines: what can we learn from the human immune response following exposure to H7 subtype viruses? Front Med. 2017 Dec; 11(4):471-479.
Score: 0.006
-
Differential T-Cell Reactivity to Endemic Coronaviruses and SARS-CoV-2 in Community and Health Care Workers. J Infect Dis. 2021 07 02; 224(1):70-80.
Score: 0.002
-
Immunological imprinting of the antibody response in COVID-19 patients. Nat Commun. 2021 06 18; 12(1):3781.
Score: 0.002
-
SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study. Lancet Respir Med. 2021 07; 9(7):712-720.
Score: 0.002
-
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine. N Engl J Med. 2021 04 08; 384(14):1372-1374.
Score: 0.002
-
SARS-CoV-2 Infection Risk Among Active Duty Military Members Deployed to a Field Hospital - New York City, April 2020. MMWR Morb Mortal Wkly Rep. 2021 03 05; 70(9):308-311.
Score: 0.002
-
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months. Science. 2020 12 04; 370(6521):1227-1230.
Score: 0.002
-
Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study. Nat Med. 2020 11; 26(11):1708-1713.
Score: 0.002
-
Pre-existing Antineuraminidase Antibodies Are Associated With Shortened Duration of Influenza A(H1N1)pdm Virus Shedding and Illness in Naturally Infected Adults. Clin Infect Dis. 2020 05 23; 70(11):2290-2297.
Score: 0.002
-
A serological assay to detect SARS-CoV-2 seroconversion in humans. Nat Med. 2020 07; 26(7):1033-1036.
Score: 0.002
-
Novel correlates of protection against pandemic H1N1 influenza A virus infection. Nat Med. 2019 06; 25(6):962-967.
Score: 0.002
-
Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model. Front Immunol. 2019; 10:756.
Score: 0.002